SEC Form 4 · accession 0001179110-16-026210
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bennett M Shapiro
Director
Period of report
Jun 1, 2016
Accepted (ET)
Jun 8, 2016 · 3:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2016 | M | 5,200 | $12.90 | A | 5,200 | D | |
| Common Stock | Jun 1, 2016 | S | 5,200 | $13.00 | D | 10,834 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $12.90 | Jun 1, 2016 | M | 5,200 | D | — | Jun 15, 2016 | Common Stock | 5,200 | 14,000 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on August 6, 2015.
- F2The option, representing a right to purchase a total of 19,200 shares was granted on June 15, 2006 and became exercisable in four equal installments, with the first installment vesting on the three-month anniversary of the grant date and each additional installment vesting at the end of each successive three-month period thereafter.